Product
CORT108297
2 clinical trials
4 indications
Indication
Mild Cognitive ImpairmentIndication
Alzheimer's diseaseIndication
Memory ImpairmentIndication
PTSDClinical trial
Phase II Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)Status: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD)Status: Recruiting, Estimated PCD: 2024-12-31